“Metabolomics” In Breast Cancer Diagnosis

Authors

  • Naila Irum Hadi

Abstract

reast cancer, the most frequent cancer in females is the major cause of morbidity and mortality in the world as well as in Pakistan. Screening of breast cancer or early detection requires a reliable biomarker that has high specificity and sensitivity for use in clinical practice. Certain diagnostic biomarker have been identified but are not fit for clinical use due to their low sensitivity like MUC1 (mucin glycoprotein) and CA 15-3 and CA 27-29 (cancer antigens)…

Additional Files

Published

2024-05-17

Issue

Vol. 4 No. 2 (2015): Vol. 04 No. 2 (2015): Pakistan Journal of Medicine and Dentistry. April-June

Section

Editorial

License

Copyright (c) 2024 Pakistan Journal of Medicine and Dentistry

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

This is an open-access article distributed under the terms of the CreativeCommons Attribution License (CC BY) 4.0 https://creativecommons.org/licenses/by/4.0/

How to Cite

1.
Naila Irum Hadi. “Metabolomics” In Breast Cancer Diagnosis. PJMD [Internet]. 2024 May 17 [cited 2026 Jun. 15];4(2). Available from: https://ojs.zu.edu.pk/pjmd/article/view/2826